已收盘 10-16 16:00:00 美东时间
-0.280
-1.52%
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 06:19
今日重点评级关注:摩根士丹利:维持TeraWulf"超配"评级,目标价从62.5美元升至65美元;摩根士丹利:维持Hut 8"超配"评级,目标价从273美元升至275美元
10-13 12:30
On Thursday, Shoulder Innovations (NYSE:SI) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. View the...
10-12 19:53
BTIG analyst Ryan Zimmerman maintains Shoulder Innovations (NYSE:SI) with a Buy and raises the price target from $26 to $27.
10-12 18:08
Shoulder Innovations, Inc. ( ($SI) ) has issued an update. Shoulder Innovations...
10-08 19:28
Limited User Release of the Company's Next-Generation InSet® Glenoid Implant Follows Successful Completion of First Surgical Case GRAND RAPIDS, Mich., Oct. 8, 2026 /PRNewswire/ -- Shoulder I...
10-08 19:00
Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that it has entered into a settlement agreement with Catalyst OrthoScience Inc. ("Catalyst") to resolve ...
09-09 04:15
GRAND RAPIDS, Mich., Sept. 8, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transf...
09-09 04:05
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
今日重点评级关注:康托·菲茨杰拉德:维持InflaRx"超配"评级,目标价从4美元升至6美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从19美元升至20美元
08-10 19:24